Publications of U. Reichl

Wolff, M. W., Kalbfuss, B., Opitz, L., Zimmermann, A., Lehmann, S., & Reichl, U.Downstream Process of Influenza VirusesPresented at: European BioPharm Scale-Up Congress 2006Geneva, Switzerland, September 12, 2006.

Genzel, Y., Schulze-Horsel, J., Möhler, L., Sidorenko, Y., & Reichl, U.Influenza Vaccines: Challenges in Mammalian Cell Culture TechnologyPresented at: 19th ESACT MeetingHarrogate, UK, June 5, 2005.

Heßeler, J., Schmidt, J. K., Reichl, U., & Flockerzi, D.How to achieve coexistence in the chemostat: a combined mathematical and experimental approachPresented at: European Conference on Mathematical and Theoretical Biology (ECMTB)Dresden, Germany, July 18, 2005.

Wolff, M., Kalbfuss, B., Morenweiser, R., Zimmermann, A., & Reichl, U.Chromatography-based Purification of Influenza A Virus for the Production of Human Whole-Virion VaccinesPresented at: Viral Vectors and Vaccines ConferenceAustin, Texas, November 14, 2005.

Wolff, M. W., Salaklang, J., Opitz, L., Schwarzer, J., Rapp, E., Kalbfuss, B., & Reichl, U.Development of a lectin-affinity chromatography step for the downstream processing of influenza virus vaccinesPresented at: AICHE Annual Meeting 2005Cincinnati, Ohio, USA, October 30, 2005.

Genzel, Y., König, S., & Reichl, U.Amino acid analysis in mammalian cell culture based virus vaccine production processesPresented at: IICS : 17th annual International Ion Chromatography SymposiumTrier, Germany, September 20, 2004.

Rapp, E., Lubda, D., Seidel-Morgenstern, A., Reichl, U., & Tallarek, U.Sheathless ESI-Interface for Coupling Capillary Separation Techniques to Mass SpectrometyPresented at: 37. Diskussionstagung der Deutschen Gesellschaft für MassenspektrometrieLeipzig, Germany, March 7, 2004.

Piasecka, J., Rüdiger, D., Küchler, J., Kupke, S. Y., & Reichl, U.Molecular basis for the antiviral activity of the influenza defective interfering particle “OP7”Presented at: 34^th Annual Meeting of the Society for VirologyHamburg (Germany), March 4, 2025.

Rüdiger, D., Piasecka, J., Küchler, J., Kupke, S. Y., & Reichl, U.The secrets of “OP7”, an influenza DIP: mathematical model, impact of mutations and antiviral mechanismsPresented at: 34^th Annual Meeting of the Society for VirologyHamburg (Germany), March 4, 2025.

Dogra, T., Pelz, L., Rüdiger, D., Hein, M. D., Böhme, J., Bälkner, M., Kershaw, O., Marichal-Gallardo, P., Gruber, A., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Genetically engineered defective interfering particles for antiviral treatment and vaccinationPresented at: 28th ESACT MeetingEdingburgh (Scotland), June 23, 2024.

Jacobtorweihe, L., Göbel, S., Wolschek, M., Altomonte, J., Reichl, U., & Genzel, Y.HCD Perfusion of CCX.E10 Quail Cells for Production of Vesicular Stomatitis Virus based oncolytic VaccinePresented at: Vaccine Technology IXLos Cabos (Mexico), May 19, 2024.

Jacobtorweihe, L., Göbel, S., Wolschek, M., Altomonte, J., Reichl, U., & Genzel, Y.Production of Oncolytic rVSV-NDV in CCX.E10 Quail Cells by HCD Perfusion CulturePresented at: Himmelfahrtstagung on Bioprocess Engineering 2024Regensburg (Germany), May 6, 2024.

Jacobtorweihe, L., Madeline, B., Léon, A., Genzel, Y., & Reichl, U.Production of Oncolytic Newcastle Disease Virus in EB66 cellsPresented at: 28th ESACT MeetingEdingburgh (Scotland), June 23, 2024.

Küchler, J., Opitz, P., Jordan, I., Genzel, Y., Benndorf, D., & Reichl, U.Quantification of intracellular influenza A virus proteins shows changes in dynamics related to host cell line and virus seedPresented at: 28th ESACT Meeting Edingburgh (Scotland), June 23, 2024.

Küchler, J., Opitz, P., Jordan, I., Genzel, Y., Benndorf, D., & Reichl, U.Quantification of intracellular influenza A virus proteins shows changes in dynamics related to host cell line and virus seedPresented at: Himmelfahrtstagung on Bioprocess Engineering 2024Regensburg (Germany), May 6, 2024.

Pelz, L., Dogra, T., Rüdiger, D., Boehme, J., Kershaw, O., Bruder, D., Kupke, S. Y., & Reichl, U.Defective Interfering Particles of Influenza A Virus As Broad-Spectrum AntiviralsPresented at: 33^rd Annual Meeting of the Society for Virology (GfV)Vienna (Austria), March 25, 2023.

Piasecka, J., Rüdiger, D., Küchler, J., Kupke, S. Y., & Reichl, U.Mechanisms of antiviral action of the influenza defective interfering particle “OP7”Presented at: 33^rd Annual Meeting of the Society for Virology (GfV)Vienna (Austria), March 25, 2023.

Piasecka, J., Rüdiger, D., Küchler, J., Kupke, S. Y., & Reichl, U.Mechanisms of antiviral action of the influenza defective interfering particle “OP7”Presented at: 28th ESACT MeetingEdinburgh (Scotland), June 23, 2024.

Rüdiger, D., Opitz, P., Kupke, S. Y., & Reichl, U.A two-dimensional model to predict coinfection of influenza A virus with defective interfering particles in tissue-like systemsPresented at: Himmelfahrtstagung on Bioprocess Engineering 2024Regensburg (Germany), May 6, 2024.

Zinnecker, T. M., Thiele, K., Schmidberger, T., Reichl, U., & Genzel, Y.Influenza A Virus Production following Quality by Design PrinciplesPresented at: Vaccine Technology IXLos Cabos (Mexico), May 19, 2024.